Picture of Baxter International logo

BAX Baxter International Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Baxter International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,0111,1101,295-2,4212,663
Depreciation
Deferred Taxes
Non-Cash Items1,0392953443,477-1,969
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital-425-272-161-1,023268
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities2,1041,8682,2221,2111,726
Capital Expenditures-696-709-743-679-692
Purchase of Fixed Assets
Other Investing Cash Flow Items-404-470-10,457-2523,905
Acquisition of Business
Other Investing Cash Flow
Cash from Investing Activities-1,100-1,179-11,200-9313,213
Financing Cash Flow Items-48-52-138-61-65
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities498-3458,245-1,438-3,489
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,497401-780-1,2341,476